These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1415071)

  • 1. Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines.
    Faden H; Duffy L
    Am J Dis Child; 1992 Nov; 146(11):1320-3. PubMed ID: 1415071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
    Faden H; Modlin JF; Thoms ML; McBean AM; Ferdon MB; Ogra PL
    J Infect Dis; 1990 Dec; 162(6):1291-7. PubMed ID: 2172403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines.
    McBean AM; Thoms ML; Albrecht P; Cuthie JC; Bernier R
    Am J Epidemiol; 1988 Sep; 128(3):615-28. PubMed ID: 2843039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants.
    Adenyi-Jones SC; Faden H; Ferdon MB; Kwong MS; Ogra PL
    J Pediatr; 1992 May; 120(5):686-9. PubMed ID: 1315853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
    Zhaori G; Sun M; Faden HS; Ogra PL
    J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines.
    Faden H; Duffy L; Sun M; Shuff C
    J Infect Dis; 1993 Aug; 168(2):452-4. PubMed ID: 8335983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The humoral immune response to type 1 oral poliovirus vaccine in children previously immunized with enhanced potency inactivated poliovirus vaccine or live oral poliovirus vaccine.
    Modlin JF; Onorato IM; McBean AM; Albrecht P; Thoms ML; Nerhood L; Bernier R
    Am J Dis Child; 1990 Apr; 144(4):480-4. PubMed ID: 2157337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the serologic responses to oral and injectable trivalent poliovirus vaccines.
    McBean AM; Thoms ML; Johnson RH; Gadless BR; MacDonald B; Nerhood L; Cummins P; Hughes J; Kinnear J; Watts C
    Rev Infect Dis; 1984; 6 Suppl 2():S552-5. PubMed ID: 6740101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
    Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
    Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey.
    Murph JR; Grose C; McAndrew P; Mickiewicz C; Mento S; Cano F; Radick L; Ritchey M; Stout MG
    Pediatr Infect Dis J; 1988 Nov; 7(11):760-5. PubMed ID: 2852791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different secretory IgA antibody responses after immunization with inactivated and live poliovirus vaccines.
    Hanson LA; Carlsson B; Jalil F; Lindblad BS; Khan SR; van Wezel AL
    Rev Infect Dis; 1984; 6 Suppl 2():S356-60. PubMed ID: 6740073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines.
    Zhaori G; Sun M; Ogra PL
    J Infect Dis; 1988 Jul; 158(1):160-5. PubMed ID: 2839578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination.
    Carlsson B; Zaman S; Mellander L; Jalil F; Hanson LA
    J Infect Dis; 1985 Dec; 152(6):1238-44. PubMed ID: 2999260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines.
    Lu CY; Kao CL; Lee CY; Lee PI; Huang LM
    J Formos Med Assoc; 2001 Aug; 100(8):513-8. PubMed ID: 11678000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.